Ludwig Hantson - Net Worth and Insider Trading
Ludwig Hantson Net Worth
The estimated net worth of Ludwig Hantson is at least $30 Million dollars as of 2024-12-27. Ludwig Hantson is the CEO of Alexion Pharmaceuticals Inc and owns about 150,696 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $28 Million. Ludwig Hantson is also the Corporate Vice President of Baxter International Inc and owns about 83,903 shares of Baxter International Inc (BAX) stock worth over $2 Million. Details can be seen in Ludwig Hantson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ludwig Hantson has not made any transactions after 2018-12-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ludwig Hantson
Ludwig Hantson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ludwig Hantson owns 4 companies in total, including Alexion Pharmaceuticals Inc (ALXN) , Hologic Inc (HOLX) , and Baxalta Inc (BXLT) among others .
Click here to see the complete history of Ludwig Hantson’s form 4 insider trades.
Insider Ownership Summary of Ludwig Hantson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2020-03-30 | director & CEO |
| HOLX | Hologic Inc | 2018-11-21 | director |
| BXLT | Baxalta Inc | 2016-06-03 | director & President and CEO |
 | | 2015-06-01 | Corporate Vice President |
Ludwig Hantson Latest Holdings Summary
Ludwig Hantson currently owns a total of 2 stocks. Among these stocks, Ludwig Hantson owns 150,696 shares of Alexion Pharmaceuticals Inc (ALXN) as of December 31, 2018, with a value of $28 Million and a weighting of 91.79%. Ludwig Hantson also owns 83,903 shares of Baxter International Inc (BAX) as of July 9, 2014, with a value of $2 Million and a weighting of 8.21%.
Latest Holdings of Ludwig Hantson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2018-12-31 | 150,696 | 182.50 | 27,502,020 |
| BAX | Baxter International Inc | 2014-07-09 | 83,903 | 29.30 | 2,458,358 |
Holding Weightings of Ludwig Hantson
Ludwig Hantson Form 4 Trading Tracker
According to the SEC Form 4 filings, Ludwig Hantson has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 3,244 shares on December 31, 2018, which brought Ludwig Hantson around $310,937.
According to the SEC Form 4 filings, Ludwig Hantson has made a total of 0 transactions in Baxter International Inc (BAX) over the past 5 years. The most-recent trade in Baxter International Inc is the sale of 24,693 shares on July 9, 2014, which brought Ludwig Hantson around $2 Million.
Insider Trading History of Ludwig Hantson
- 1
Ludwig Hantson Trading Performance
GuruFocus tracks the stock performance after each of Ludwig Hantson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ludwig Hantson is 22.55%. GuruFocus also compares Ludwig Hantson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ludwig Hantson within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ludwig Hantson's insider trading performs compared to the benchmark.
Performance of Ludwig Hantson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.38 | | | | | |
| Relative Return to S&P 500(%) | 6.5 | | | | | |
Ludwig Hantson Ownership Network
Ludwig Hantson Owned Company Details
What does Alexion Pharmaceuticals Inc do?
Who are the key executives at Alexion Pharmaceuticals Inc?
Ludwig Hantson is the director & CEO of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .
Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alexion Pharmaceuticals Inc Insider Transactions
Ludwig Hantson Mailing Address
Above is the net worth, insider trading, and ownership report for Ludwig Hantson. You might contact Ludwig Hantson via mailing address: C/o Alexion Pharmaceuticals, Inc, 100 College Street, New Haven Ct 06510.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
